What innovative pricing strategy did Broad Institute and UC Berkeley initially adopt for CRISPR technology licensing that helped accelerate scientific research?

The commercialization of scientific breakthroughs involves complex pricing strategies that balance accessibility, research investment recovery, and ethical considerations. CRISPR gene-editing technology represents one of the most significant scientific advances of the 21st century, but its pricing and licensing have sparked debates throughout the scientific community. This poll tests your knowledge about how this revolutionary technology was brought to market.

This is a live public trivia poll on AIPolls.Net. Vote and see real-time results.

Dual-tier licensing: free for academic research but commercial licensing fees for companies
Blockchain-based micropayment system where researchers pay per successful edit
Universal premium pricing with 5-year exclusive licensing to highest bidders
Subscription model where labs pay monthly fees based on institution size